Edition:
India

CSPC Pharmaceutical Group Ltd (1093.HK)

1093.HK on Hong Kong Stock

15.34HKD
22 Sep 2020
Change (% chg)

HK$-0.16 (-1.03%)
Prev Close
HK$15.50
Open
HK$15.50
Day's High
HK$15.60
Day's Low
HK$15.28
Volume
24,192,124
Avg. Vol
45,020,715
52-wk High
HK$18.17
52-wk Low
HK$10.93

Latest Key Developments (Source: Significant Developments)

CSPC Pharmaceutical Says Unit's "Duloxetine Hydrochloride Enteric Capsules (20Mg, 30Mg, 60Mg)" Obtained Drug Registration Approval By NMPA
Monday, 27 Jul 2020 

July 27 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::UNIT'S "DULOXETINE HYDROCHLORIDE ENTERIC CAPSULES (20MG, 30MG, 60MG)" OBTAINED DRUG REGISTRATION APPROVAL BY NMPA.  Full Article

CSPC Pharmaceutical Unit's "Acarbose Tablets (50Mg)" Got Drug Registration Approval
Tuesday, 21 Jul 2020 

July 21 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::UNIT'S "ACARBOSE TABLETS (50MG)" OBTAINED DRUG REGISTRATION APPROVAL BY NMPA.  Full Article

Cspc Pharmaceutical Says Celecoxib Capsules Obtained Drug Registration Approval
Tuesday, 14 Jul 2020 

July 14 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::CELECOXIB CAPSULES OBTAINED DRUG REGISTRATION APPROVAL FROM NMPA.  Full Article

Cspc Pharmaceutical Says "Docetaxel For Injection (Albumin-Bound)" Got Nod To Conduct Clinical Trials In China
Tuesday, 19 May 2020 

May 19 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::CSPC PHARMACEUTICAL-"DOCETAXEL FOR INJECTION (ALBUMIN-BOUND)" DEVELOPED BY UNIT GOT APPOVAL GRANTED BY NMPA OF PRC TO CONDUCT CLINICAL TRIALS IN CHINA.  Full Article

CSPC Pharmaceutical Group Says FY Prelim Net Profit Attributable Expected To Increase By 15% To 30%
Wednesday, 22 Jan 2020 

Jan 22 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::CSPC PHARMACEUTICAL GROUP LTD - FY PRELIM NET PROFIT ATTRIBUTABLE EXPECTED TO INCREASE BY 15% TO 30% VERSUS LAST YEAR.  Full Article

CSPC Pharmaceutical Group Says Glutathione For Injection Granted Drug Registration Approval
Thursday, 26 Sep 2019 

Sept 26 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::GLUTATHIONE FOR INJECTION GRANTED DRUG REGISTRATION APPROVAL BY PRC'S NATIONAL MEDICAL PRODUCTS ADMINISTRATION.  Full Article

CSPC Pharmaceutical Group Says ALMB-0168 Granted Orphan-Drug Designation By U.S. FDA
Monday, 23 Sep 2019 

Sept 23 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::ALMB-0168 GRANTED ORPHAN-DRUG DESIGNATION BY U.S. FOOD AND DRUG ADMINISTRATION FOR TREATMENT OF OSTEOSARCOMA.GROUP PLANS TO FILE FIRST-IN-HUMAN CLINICAL STUDY APPLICATION FOR ALMB-0168 IN Q4 OF 2019.  Full Article

Cspc Pharmaceutical Says Recombinant Anti-Her2 & Anti-Cd3 Granted Clinical Trial Approval By U.S. FDA
Monday, 2 Sep 2019 

Sept 2 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::RECOMBINANT ANTI-HER2 & ANTI-CD3 HUMANIZED BISPECIFIC ANTIBODY FOR INJECTION GRANTED CLINICAL TRIAL APPROVAL BY U.S. FDA.  Full Article

CSPC Pharmaceutical Group Says New Target Anti-Tumor Drug Granted Clinical Trial Approval
Monday, 29 Jul 2019 

July 29 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::NEW TARGET ANTI-TUMOR DRUG "SYHA1807" GRANTED CLINICAL TRIAL APPROVAL BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION.  Full Article

CSPC Pharmaceutical Group Sees Jan-June Net Profit Attributable Increased By 12% To 30% Of Cspc Innovation Pharmaceutical Co
Friday, 12 Jul 2019 

July 12 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::SEES JAN-JUNE NET PROFIT ATTRIBUTABLE INCREASED BY 12% TO 30% OF CSPC INNOVATION PHARMACEUTICAL CO.  Full Article

Alibaba Health raises $1.3 billion in HK's biggest secondary share sale in 5 years

HONG KONG Alibaba Health Information Technology has raised nearly $1.3 billion in Hong Kong's largest follow-on share sale since 2015, and industry experts say this could prompt more firms to tap investors for cash in the Asian financial hub.